169 related articles for article (PubMed ID: 1693514)
21. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.
Kalams SA; Johnson RP; Trocha AK; Dynan MJ; Ngo HS; D'Aquila RT; Kurnick JT; Walker BD
J Exp Med; 1994 Apr; 179(4):1261-71. PubMed ID: 8145043
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus.
Letvin NL; Schmitz JE; Jordan HL; Seth A; Hirsch VM; Reimann KA; Kuroda MJ
Immunol Rev; 1999 Aug; 170():127-34. PubMed ID: 10566147
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Carmichael A; Jin X; Sissons P; Borysiewicz L
J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
[TBL] [Abstract][Full Text] [Related]
24. Implications of HIV-specific cytotoxic T lymphocytes in AIDS.
Plata F
Biotherapy; 1992; 5(1):31-45. PubMed ID: 1389901
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells.
Johnson RP; Trocha A; Yang L; Mazzara GP; Panicali DL; Buchanan TM; Walker BD
J Immunol; 1991 Sep; 147(5):1512-21. PubMed ID: 1715361
[TBL] [Abstract][Full Text] [Related]
26. Structural constraints on viral escape from HIV- and SIV-specific cytotoxic T-lymphocytes.
Peyerl FW; Barouch DH; Letvin NL
Viral Immunol; 2004; 17(2):144-51. PubMed ID: 15279695
[TBL] [Abstract][Full Text] [Related]
27. Detection of CTL activity in PBMCS taken from HIV-ENV immunized individuals after in vitro viral infection.
Achour A; Moukrim Z; Zagury JF; Picard O; Burny A; Zagury D
Biomed Pharmacother; 1994; 48(1):7-10. PubMed ID: 7919102
[TBL] [Abstract][Full Text] [Related]
28. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
[TBL] [Abstract][Full Text] [Related]
29. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex.
Jassoy C; Johnson RP; Navia BA; Worth J; Walker BD
J Immunol; 1992 Nov; 149(9):3113-9. PubMed ID: 1383338
[TBL] [Abstract][Full Text] [Related]
30. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
[TBL] [Abstract][Full Text] [Related]
31. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.
Koziel MJ; Walker BD
Springer Semin Immunopathol; 1997; 19(1):69-83. PubMed ID: 9266632
[TBL] [Abstract][Full Text] [Related]
33. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
[TBL] [Abstract][Full Text] [Related]
34. NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection.
Fauci AS; Gallo RC; Koenig S; Salk J; Purcell RH
Ann Intern Med; 1989 Mar; 110(5):373-85. PubMed ID: 2464961
[TBL] [Abstract][Full Text] [Related]
35. Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
Vogel TU; Reynolds MR; Fuller DH; Vielhuber K; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Marthas ML; Erfle V; Wolinsky SM; Wang C; Allison DB; Rud EW; Wilson N; Montefiori D; Altman JD; Watkins DI
J Virol; 2003 Dec; 77(24):13348-60. PubMed ID: 14645590
[TBL] [Abstract][Full Text] [Related]
36. Challenges in the search for an HIV vaccine.
Lemckert AA; Goudsmit J; Barouch DH
Eur J Epidemiol; 2004; 19(6):513-6. PubMed ID: 15330122
[TBL] [Abstract][Full Text] [Related]
37. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
[TBL] [Abstract][Full Text] [Related]
38. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
39. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
[TBL] [Abstract][Full Text] [Related]
40. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope.
Safrit JT; Andrews CA; Zhu T; Ho DD; Koup RA
J Exp Med; 1994 Feb; 179(2):463-72. PubMed ID: 8294860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
